KN Stock Analysis: Knowles Cor | NYSE
Electronic Components | NYSE, USA | Market Cap: 3.147m USD | 12M Return: 104.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.7M
EPS Trend: 77.8%
Qual. Beats: 1
Rev. Trend: -22.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Knowles Corporation (NYSE: KN) is a U.S.-based electronic components company operating through two segments: Precision Devices (PD), which supplies capacitors and RF solutions for defense, industrial, medtech, and electrification/energy applications, and Medtech & Specialty Audio (MSA), which produces balanced armature speakers and microphones primarily for hearing health and other specialty audio markets. Founded in 1946 and headquartered in Itasca, Illinois, the company manufactures film, electrolytic, and mica capacitors and serves customers including OEMs and their contract manufacturers, suppliers, sales representatives, and distributors across the Americas, Europe, and Asia.
Within the Information Technology sector (Electronic Components sub-industry), Knowles occupies a specialized niche in high-reliability passive components and acoustic transducers. Its balanced armature technology is widely used in hearing aids, giving the MSA segment a meaningful position in the global hearing health device supply chain.
- Precision Devices revenue grows on defense and electrification demand
- MSA segment margins expand as hearing health market recovers
- Film and electrolytic capacitor demand rises with EV and energy adoption
| Net Income: 55.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.17 > 1.0 |
| NWC/Revenue: 33.63% < 20% (prev 30.83%; Δ 2.80% < -1%) |
| CFO/TA 0.11 > 3% & CFO 112.0m > Net Income 55.9m |
| Net Debt (131.0m) to EBITDA (118.8m): 1.10 < 3 |
| Current Ratio: 3.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.7m) vs 12m ago -0.11% < -2% |
| Gross Margin: 41.91% > 18% (prev 40.01%; Δ 1.91% > 0.5%) |
| Asset Turnover: 57.10% > 50% (prev 50.35%; Δ 6.75% > 0%) |
| Interest Coverage Ratio: 10.16 > 6 (EBIT TTM 82.3m / Interest Expense TTM 8.10m) |
| A: 0.20 (Total Current Assets 297.4m - Total Current Liabilities 90.9m) / Total Assets 1.05b |
| B: -0.53 (Retained Earnings -559.7m / Total Assets 1.05b) |
| C: 0.08 (EBIT TTM 82.3m / Avg Total Assets 1.08b) |
| D: 2.85 (Book Value of Equity 780.2m / Total Liabilities 273.7m) |
| Altman-Z'' = 3.06 = A |
| DSRI: 0.92 (Receivables 109.2m/106.9m, Revenue 614.1m/552.4m) |
| GMI: 0.95 (GM 40.01% / 41.91%) |
| AQI: 1.01 (AQ_t 0.56 / AQ_t-1 0.56) |
| SGI: 1.11 (Revenue 614.1m / 552.4m) |
| TATA: -0.05 (NI 55.9m - CFO 112.0m) / TA 1.05b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 37.24 with a total of 917,461 shares traded. Over the past week, the price has changed by -8.07%, over one month by -2.54%, over three months by +33.29% and over the past year by +104.28%.
Current recommended Stop Loss: 34.90 (which is 6.3% or 1.2 ATR below the current price).
Knowles Cor has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KN.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.3 | -2.7% |
P/E Trailing = 51.8028
P/E Forward = 15.2439
P/S = 5.1244
P/B = 4.0335
P/EG = 0.43
Revenue TTM = 614.1m USD
EBIT TTM = 82.3m USD
EBITDA TTM = 118.8m USD
Long Term Debt = 131.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.90m USD (from shortTermDebt, last quarter)
Debt = 172.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 20.5m
Net Debt = 131.0m USD (calculated: Debt 172.0m - CCE 41.0m)
Enterprise Value = 3.28b USD (3.15b + Debt 172.0m - CCE 41.0m)
Interest Coverage Ratio = 10.16 (Ebit TTM 82.3m / Interest Expense TTM 8.10m)
EV/FCF = 44.84x (Enterprise Value 3.28b / FCF TTM 73.1m)
FCF Yield = 2.23% (FCF TTM 73.1m / Enterprise Value 3.28b)
FCF Margin = 11.90% (FCF TTM 73.1m / Revenue TTM 614.1m)
Net Margin = 9.10% (Net Income TTM 55.9m / Revenue TTM 614.1m)
Gross Margin = 41.91% ((Revenue TTM 614.1m - Cost of Revenue TTM 356.7m) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 42.23%)
Tobins Q-Ratio = 3.11 (Enterprise Value 3.28b / Total Assets 1.05b)
Interest Expense / Debt = 4.71% (Interest Expense 8.10m / Debt 172.0m)
Taxrate = 15.63% (11.6m / 74.2m)
NOPAT = 69.4m (EBIT 82.3m * (1 - 15.63%))
Current Ratio = 3.27 (Total Current Assets 297.4m / Total Current Liabilities 90.9m)
Debt / Equity = 0.22 (Debt 172.0m / totalStockholderEquity, last quarter 780.2m)
Debt / EBITDA = 1.10 (Net Debt 131.0m / EBITDA 118.8m)
Debt / FCF = 1.79 (Net Debt 131.0m / FCF TTM 73.1m)
Total Stockholder Equity = 763.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 55.9m / Total Assets 1.05b)
RoE = 7.32% (Net Income TTM 55.9m / Total Stockholder Equity 763.5m)
RoCE = 9.20% (EBIT 82.3m / Capital Employed (Equity 763.5m + L.T.Debt 131.0m))
RoIC = 7.41% (NOPAT 69.4m / Invested Capital 937.2m)
WACC = 11.01% (E(3.15b)/V(3.32b) * Re(11.39%) + D(172.0m)/V(3.32b) * Rd(4.71%) * (1-Tc(0.16)))
Discount Rate = 11.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.91 | Cagr: -1.48%
[DCF] Terminal Value 63.87% ; FCFF base≈83.8m ; Y1≈73.5m ; Y5≈59.4m
[DCF] Fair Price = 6.24 (EV 664.8m - Net Debt 131.0m = Equity 533.8m / Shares 85.6m; r=11.01% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 77.85 | EPS CAGR: 8.54% | SUE: 2.68 | # QB: 1
Revenue Correlation: -22.15 | Revenue CAGR: -1.87% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.30 | Chg30d=+4.27% | Revisions=+40% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=+0.00% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=1.29 | Chg30d=+4.23% | Revisions=+57% | GrowthEPS=+16.4% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=1.56 | Chg30d=+4.06% | Revisions=+50% | GrowthEPS=+20.5% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: +64% (up=10, down=1)